Active Ingredient(s):Anagrelide FDA Approved: * March 14, 1997 Pharm Company: *SHIRE Category:Blood Volume
Anagrelide (Agrylin/Xagrid, Shire and Thromboreductin, AOP Orphan Pharmaceuticals AG) is a drug used for the treatment of essential thrombocytosis (also known as essential thrombocythemia), or overproduction of blood platelets. It also has been used in the treatment of chronic myeloid leukemia.
Anagrelide controlled release (GALE-401) is in phase III clinical trials by Galena Biopharma for the treatment of essential thrombocytosis.
1 Medical us...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion